Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smartphone-Based Optical Imaging Offers Onsite Diagnostics

By LabMedica International staff writers
Posted on 08 Feb 2017
A novel smartphone-based optical imaging and molecular assay system permits on-site diagnostics and facilitates transfer of molecular diagnostic data from the point-of-care (POC) to the point-of-expertise, providing a cost-effective means for molecular diagnostics even in resource-limited settings.

The device, which can image and analyze specific DNA sequences and genetic mutations in tumor cells and tissue samples without prior DNA extraction, was developed through the collaborative efforts of a group of investigators at the University of California, Los Angeles, Stockholm University, and Uppsala University.

The investigators used a three-dimensional printer to produce a lightweight optical attachment to be used with a standard smartphone camera. More...
The device is able to capture multi-color fluorescence and bright-field images of the same quality as those obtained by traditional light microscopy.

The device analyzes a tissue or cell sample in a dedicated container by recording multi-mode images of the sample during processing and feeding the data to an algorithm. The algorithm automatically analyzes the images to read the sequenced bases of the extracted tumor DNA and identifies genetic mutations directly inside the tumor tissue.

“It is very important to have these molecular testing approaches at a doctor’s office or where care is being given,” said senior author Dr. Mats Nilsson, professor of biochemistry and biophysics at Stockholm and Uppsala Universities. “Oftentimes, advanced lab-based testing is performed at major hospitals, which is limiting, as not everyone has access to a hospital that can perform these tests.”

The device was described in detail in the January 17, 2017, online edition of the journal Nature Communications.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
All-in-One Molecular System
AIO M160
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.